TABLE 2.
Index/author | States/Regions | Total studies (N) a | Number of studies by cancer control outcome | ||||
---|---|---|---|---|---|---|---|
Risk/incidence (N) | Screening (N) | Diagnosis (N) | Treatment (N) | Survival/mortality (N) | |||
Yost index 44 | CA (n = 37); SEER‐18 participating regions (n = 1); National (n = 1) | 40 | 16 | — | 6 | 3 | 22 |
Concentrated disadvantage (6 variables) 132 | IL (n = 4); LA (n = 2) | 6 | 1 | — | 3 | 1 | 2 |
Messer index 22 | AR, KY, MS, SC, TN, VA, WV (n = 1 each); CA, MI, NJ (n = 2 each); FL, GA, LA, NC, PA (n = 3 each) | 4 | 1 | — | 2 | — | 2 |
Yang index 141 | CA | 4 | 2 | — | — | — | 2 |
Concentrated affluence 43 | IL | 3 | — | — | 1 | 1 | 1 |
Diez‐Roux index 134 | WA | 2 | 1 | — | — | — | 1 |
Lian index 88 | CA, FL, GA, LA, MI, MO, NC, NJ, PA (n = 1 each) | 2 | — | — | — | — | 2 |
Area deprivation index 131 | OH | 1 | 1 | — | — | — | — |
Banegas index 29 | CA | 1 | — | — | 1 | — | 1 |
Beyer index 97 | National (100 metropolitan areas) | 1 | — | — | — | — | 1 |
Concentrated disadvantage (2 variables) 30 | IL | 1 | — | — | 1 | — | — |
Coogan index 133 | Southeastern US (AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, VA, WV) | 1 | — | — | — |
— |
1 |
Doubeni index 86 | 6 US states (CA, FL, LA, NJ, NC, PA) or 2 metropolitan areas (Atlanta, Georgia; Detroit, Michigan) | 1 | 1 | — | — | — | — |
Dubowitz index 135 | PA | 1 | — | — | — | 1 | — |
ICE ‐ income 136 , 137 | NJ | 1 | — | — | — | — | 1 |
Johnson economic deprivation index 94 | GA | 1 | — | — | — | 1 | 1 |
Material deprivation index 138 | MI | 1 | — | — | — | 1 | — |
Mojica index 38 | CA | 1 | — | — | 1 | — | — |
Neighborhood deprivation index 139 | AL, AR, FL, GA, KY, LA, MS, NC, SC, TN, VA, WV | 1 | 1 | — | — | — | — |
Palmer index 39 | CA, GA, IL, MA, NJ, NY, VA, Washington DC | 1 | 1 | — | 1 | — | — |
Reitzel index 98 | LA; TX | 1 | — | — | — | — | 1 |
Social deprivation index 140 | VA | 1 | — | 1 | — | — | — |
Wheeler index 28 | MN; WI | 1 | — | 1 | — | — | — |
Zhang index 90 | CA, FL, GA, LA, MI, NJ, NC, PA | 1 | 1 | — | — | — | — |
Because several studies utilized the same nSES index for multiple cancer control outcomes, the number of studies listed across the cancer control outcomes may not add up to the total studies.